Biggest News Aggregation in the World
๐Ÿ“ฐ Anna Padula News

Anna Padula News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Anna Padula. Real-time updates on events, politics, business and more.

Gilead Sciences, Inc.: Kite's Tecartus CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

-- In Three-Year Follow-up in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia, Tecartus Shows High Rates of Durable Response (CR+CRi 71%) and a Median Overall Survival of 26 Months
United States Santa Monica Foster City Bijal Shah Jacquie Ross Schwierige Zeiten

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Gilead Sciences, Inc.: Kite's CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)

-- Approval Marks Kite's Fourth Indication in Europe for its Two Cell Therapies and First in Leukemia -- -- Overall Complete Remission of 71% and a Median Overall Survival of More Than Two Years
United States Santa Monica Foster City Christi Shaw Jacquie Ross Maxs Topp

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science